Infobip is set to launch AgentOS to orchestrate autonomous AI-driven customer journeys at scale
New platform reinforces Infobip's shift to AI-first customer experience in its 20th year KUALA LUMPUR, Malaysia, March 2, 2026 /PRNewswire/ -- Global AI-first cloud communications platform Infobip, which celebrates its 20th anniversary this year, is...
SK Telecom CEO Unveils 'AI Native' Strategy at MWC26, Driving Korea's Leap in AI Innovation
- Seizing the golden time for a major transformation, with 'Customer Value & AI' as the top two priorities for driving change - Major overhaul of systems and infrastructure, the foundation of telecommunications, centered on AI - Redesigning...
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three...
Firmable Raises $14m Series A to Take AI-Native Sales Platform Global
MELBOURNE, Australia, March 2, 2026 /PRNewswire/ -- Firmable, Asia-Pacific's leading AI (artificial intelligence) sales platform, has raised $14 million in Series A funding led by Airtree, with participation from existing investors. The funding will...
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis
SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today...
Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves
SINGAPORE, March 2, 2026 /PRNewswire/ -- Toku Ltd. ("Toku", "投酷有限公司" or the "Company", and together with its subsidiaries, the "Group"), a Singapore-incorporated AI-powered customer experience (CX) platform, is pleased to announce its financial...
Understanding China's whole-process people's democracy
BEIJING, March 2, 2026 /PRNewswire/ -- A report from People's Daily: The upcoming "two sessions," the annual meetings of China's top legislature, the National People's Congress (NPC), and the top political advisory body, the National Committee of...
Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
SAN FRANCISCO and SUZHOU, China, March 2, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...